Lymphoseek tilmanocept regulatory update

FDA accepted for review an NDA from Neoprobe for Lymphoseek tilmanocept for use in intraoperative lymphatic mapping (ILM). The NDA for theTc99m-labeled radioactive tracing agent was submitted on Aug. 10. A standard 10-month review would place the PDUFA date around June 2012. ...